Review
Copyright ©2014 Baishideng Publishing Group Inc.
World J Hepatol. Jun 27, 2014; 6(6): 384-393
Published online Jun 27, 2014. doi: 10.4254/wjh.v6.i6.384
Figure 2
Figure 2 Management of occult hepatitis B infection in hematological and rheumatological diseases and in solid cancers. 1Entecavir instead of Lamivudine, when appropriate. HBsAg: Hepatitis B surface antigen; ALT: Alanine aminotransferase; Anti-HBc: Hepatitis B core antigen; TNF-α: Tumor necrosis factors-alpha.